Prediction of Renal Damage Complicated by Hypertension With Uric Acid and Serum Cystatin C as Early Marker

Advances in Clinical Medicine
doi 10.12677/acm.2013.34007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hans Publishers

Related search

Serum Cystatin C: An Early Marker of Organ Damage in Patients With Arterial Hypertension

High Blood Pressure and Cardiovascular Prevention
Internal MedicineCardiovascular MedicineCardiology
2007English

Serum Cystatin C Compared to Serum Creatinine as an Early Marker of Renal Failure

International Journal of Current Microbiology and Applied Sciences
2017English

Serum Uric Acid and Target Organ Damage in Essential Hypertension

Vascular Health and Risk Management
2014English

Evaluation of Serum Cystatin C Concentration as a Marker of Renal Function in Patients With Cirrhosis of the Liver

Gut
Gastroenterology
2002English

Association of Serum Lipids, Oxidative Stress and Serum Cystatin C With Prehypertension and Hypertension

International Journal of Medical Research and Review
2014English

The Controversial Role of Serum Uric Acid in Essential Hypertension: Relationships With Indices of Target Organ Damage

Journal of Human Hypertension
Internal Medicine
2005English

Serum Cystatin C an Early Indicator of Renal Function Decline in Type 2 Diabetes

American Journal of BioScience
2014English

Serum Uric Acid and the Incidence of CKD and Hypertension

Clinical and Experimental Nephrology
PhysiologyNephrology
2015English

Serum Cystatin C Is a Better Marker of Topotecan Clearance Than Serum Creatinine

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy